Lenalidomide for treating myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality

  • Technology appraisal guidance
  • TA322
  • Published: 
  • Last updated: 
Download (PDF)

Why has NICE said this?

Lenalidomide was recommended because the benefits to patients justify its cost.

NICE looks at how well treatments work in relation to how much they cost compared with other treatments available on the NHS.

  • Information Standard